
![]() | Read in Browser | |||||||||
![]() | ||||||||||
|
"We've heard from many of you that the impact on your advertising investment has been greater than you expected," Product Marketing VP Graham Mudd says. "The cost of achieving your business outcome may have increased and it's also gotten harder to measure your campaigns on our platform." Some of that is due to underreporting, he says, adding that "we believe that real world conversions, like sales and app installs, are higher than what is being reported for many advertisers." (121 comments) FireEye (NASDAQ:FEYE) to relaunch as Mandiant in October.
Facebook (NASDAQ:FB) tech chief to exit role; Hardware head taking over.
U.S. crude (CL1:COM) stockpiles post seventh straight weekly decline.
Will Nike (NYSE:NKE) overcome its Vietnam, China issues and post Q1 earnings surprise?
Remittances provider Remitly (NASDAQ:RELY) prices IPO above range at $43.
Crypto mining firm Argo (ARBK) prices 7.5M-ADS IPO at $15.
Identity verification provider Sterling (NASDAQ:STER) prices 14.3M-share IPO above range at $23.
Equinor (NYSE:EQNR) a likely winner from surging European natural gas prices, HSBC says.
Download Seeking Alpha for your Phone or Tablet
Want More Ideas?
Our best ideas → Stock Ideas
ETF's Investing Ideas → ETF Ideas
Dividend stocks ideas → Dividend Ideas
This email was sent to you because you signed up to receive Wall Street Breakfast.
If you do not want to receive Wall Street Breakfast emails, click here to unsubscribe.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017
Covid
The FDA has granted Emergency Use Authorization for a booster dose of Pfizer (NYSE:PFE)/BioNTech's (NASDAQ:BNTX) COVID-19 vaccine for those 65 and older, those who work in healthcare settings, and adults at high risk of severe COVID-19.
The authorization includes people whose "frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19." The agency said individuals in these groups can get a booster dose as long as it has been at least six months since they received a second shot. (10 comments)
The authorization includes people whose "frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19." The agency said individuals in these groups can get a booster dose as long as it has been at least six months since they received a second shot. (10 comments)
Today's Markets
In Asia, Japan Closed. Hong Kong +1.0%. China +0.38%. India +1.39%.
In Europe, at midday, London +0.52%. Paris +1.06%. Frankfurt +1.07%.
Futures at 6:20, Dow +0.71%. S&P +0.73%. Nasdaq +0.71%. Crude +0.06% at $72.27. Gold -0.6% at $1768. Bitcoin +3.6% at $43862.
Ten-year Treasury Yield +5 bps to 1.335%
In Europe, at midday, London +0.52%. Paris +1.06%. Frankfurt +1.07%.
Futures at 6:20, Dow +0.71%. S&P +0.73%. Nasdaq +0.71%. Crude +0.06% at $72.27. Gold -0.6% at $1768. Bitcoin +3.6% at $43862.
Ten-year Treasury Yield +5 bps to 1.335%
Today's Economic Calendar
What else is happening...
Facebook (NASDAQ:FB) tech chief to exit role; Hardware head taking over.
U.S. crude (CL1:COM) stockpiles post seventh straight weekly decline.
Will Nike (NYSE:NKE) overcome its Vietnam, China issues and post Q1 earnings surprise?
Remittances provider Remitly (NASDAQ:RELY) prices IPO above range at $43.
Crypto mining firm Argo (ARBK) prices 7.5M-ADS IPO at $15.
Identity verification provider Sterling (NASDAQ:STER) prices 14.3M-share IPO above range at $23.
Equinor (NYSE:EQNR) a likely winner from surging European natural gas prices, HSBC says.


Want More Ideas?
Our best ideas → Stock Ideas
ETF's Investing Ideas → ETF Ideas
Dividend stocks ideas → Dividend Ideas
This email was sent to you because you signed up to receive Wall Street Breakfast.
If you do not want to receive Wall Street Breakfast emails, click here to unsubscribe.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017
EmoticonEmoticon